Merck & Co. Other intangible assets—net decreased by 3.5% to $25.75B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 63.4%, from $15.76B to $25.75B. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows an upward trend with a 13.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase typically signals recent strategic acquisitions or significant investment in R&D and intellectual property, while a decrease reflects ongoing amortization or potential impairment.
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software...
High in semiconductor and tech firms due to heavy reliance on patent portfolios and acquired technology.
non_current_assets_intangible_assets_net_excluding_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.62B | $13.38B | $22.93B | $23.02B | $22.50B | $21.37B | $20.27B | $19.86B | $19.67B | $19.20B | $18.01B | $17.57B | $16.98B | $17.01B | $16.37B | $15.76B | $15.19B | $15.31B | $26.68B | $25.75B |
| QoQ Change | — | -1.7% | +71.3% | +0.4% | -2.3% | -5.0% | -5.1% | -2.0% | -1.0% | -2.4% | -6.2% | -2.4% | -3.3% | +0.2% | -3.8% | -3.7% | -3.6% | +0.8% | +74.2% | -3.5% |
| YoY Change | — | — | — | — | +65.2% | +59.7% | -11.6% | -13.7% | -12.6% | -10.2% | -11.1% | -11.5% | -13.6% | -11.4% | -9.1% | -10.3% | -10.5% | -10.0% | +63.0% | +63.4% |
| Segment | Q4 '25 |
|---|---|
| Keytruda Qlex | $930.00M |
| Total | $26.68B |
Keytruda Qlex was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.